The nephrotic syndrome: current concepts in diagnosis and therapy advantages of alternate day steroid regimen.
D000477:Alkylating Agents / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004976:Ethacrynic Acid / Q000008:administration & dosage*; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage*; D006852:Hydrochlorothiazide / Q000008:administration & dosage*; D008466:Mechlorethamine / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage*; D012110:Reserpine / Q000008:administration & dosage*; D013866:Thioguanine / Q000627:therapeutic use*
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D006852:Hydrochlorothiazide; D006830:Hydralazine; D008466:Mechlorethamine; D012110:Reserpine; D015122:Mercaptopurine; D013866:Thioguanine; D004976:Ethacrynic Acid; D011241:Prednisone